Quiz
Article
NeurologyLive® Brain Games: August 24, 2025
Author(s):
Key Takeaways
- NeurologyLive Brain Games offers weekly quizzes on diverse neurology topics, crafted by field experts.
- The quizzes cover dementia, Alzheimer’s, epilepsy, headache, movement disorders, multiple sclerosis, neuromuscular disorders, sleep disorders, and stroke.
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is on the use of GLP-1 RAs in neurology.
Welcome to NeurologyLive® Brain Games! This weekly quiz series, which goes live every Sunday morning, will feature questions on a variety of clinical and historical neurology topics, written by physicians, clinicians, and experts in the fields of neurological care and advocacy.
Test your mettle each week with 3 questions that cover a variety of aspects in the field of neurology, with a focus on dementia and Alzheimer disease, epilepsy and seizure disorders, headache and migraine, movement disorders, multiple sclerosis, neuromuscular disorders, sleep disorders, and stroke and cerebrovascular disease.
This week's questions include the theme of the GLP-1 RAs to treat neurologic conditions.
Click here to check out the prior iterations of Brain Games.
Interested in submitting quiz questions? Contact our editor, Marco Meglio, via email: mmeglio@neurologylive.com.
Which potential neuroprotective mechanism of GLP-1 receptor agonists has been most consistently demonstrated in preclinical models of neurodegenerative disease?
Which GLP-1 receptor agonist has advanced to phase 2 clinical trials for Parkinson disease, showing signals of disease modification?
What is the proposed rationale for investigating GLP-1 RAs in Alzheimer disease?
How did you do on this week's quiz? Let us know with a response to the poll below. Don't forget to share and compare your results with your friends!
How many questions did you get correct?
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
